Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Electromed, Inc. To Participate in the Dougherty & Co. Institutional Investor Conference on September 19, 2017 in Minneapolis

Posted on: 07 Sep 17

Electromed, Inc. (NYSE MKT:ELMD), a leader in innovative airway clearance technologies, today announced that management will participate in the Dougherty & Co. Institutional Investor Conference in Minneapolis, Minnesota on September 19, 2017. The conference is taking place at the Millennium Hotel in downtown Minneapolis.

Kathleen Skarvan, President and Chief Executive Officer, and Jeremy Brock, Chief Financial Officer, will be available for one-on-one meetings with attendees throughout the day. To schedule a meeting with management, please contact a Dougherty & Co. representative or The Equity Group, Electromed’s investor relations firm. A copy of management’s presentation will be available in the investor relations section of Electromed’s website at

About Electromed, Inc.

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about Electromed can be found at

View source version on

Business Wire

Last updated on: 07/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.